Application of stem cell/growth factor system, as a multimodal therapy approach in regenerative medicine to improve cell therapy yields

作者：Pourrajab Fatemeh^*; Zarch Mojtaba Babaei; Yazdi Mohammad Baghi; Zarchi Abolfazl Rahimi; Zarch Abbas Vakili

来源：International Journal of Cardiology, 2014, 173(1): 12-19.

DOI：10.1016/j.ijcard.2014.02.006

• Regenerative medicine
• Growth factors
• Stem cell

Stem cells hold a great promise for regenerative medicine, especially for replacing cells in infarcted organ that hardly have any intrinsic renewal capacity, including heart and brain. Signaling pathways that regulate pluripotency or lineage-specific gene and protein expression have been the major focus of stem cell research. Between them, there are some well known signaling pathways such as GF/GFR systems, SDF-1 alpha/CXC4 ligand receptor interaction and PI3K/Akt signaling, and cytokines may regulate cell fate decisions, and can be utilized to positively influence cell therapy outcomes or accentuate synergistic compliance. For example, contributing factors in the progression of heart failure are both the loss of cardiomyocytes after myocardial infarction, and the absence of an adequate endogenous repair signaling. Combining cell engraftment with therapeutic signaling factor delivery is more exciting in terms of host progenitor/donor stem cell survival and proliferation. Thus stem cell-based therapy, besides triggering signaling pathways through GF/GFR systems can become a realistic option in regenerative processes for replacing lost cells and reconstituting the damaged organ, as before.

• 出版日期2014-4-15